Navigation Links
DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
Date:1/25/2008

DAVOS, Switzerland, Jan. 25 /PRNewswire-FirstCall/ -- DuPont Senior Vice President and Chief Science & Technology Officer Uma Chowdhry offered her perspectives on the importance of science in the formation of global policy during a discussion at the World Economic Forum here today.

"The role of science is to inform the policymaking process, to help understand both benefits and risks, and to inform the limits of what is knowable, and what is possible," Chowdhry said. "Future progress requires a symbiotic relationship between science and policy in order to secure a lasting and sustainable future for ourselves and generations to come. Policy balances many societal interests. The role of science in this discourse should be to inform but not fully define that balance."

Chowdhry participated in a forum panel "Science and the Global Agenda" which considered the relationship between science and public policy, and outlined how science can inform policymaking in the future. The discussion addressed aging societies, climate change, disease eradication, nuclear non- proliferation and environmental degradation, and the important scientific dimensions that must be considered.

"The magnitude of the challenges that we are discussing requires major advances in our scientific knowledge and understanding," Chowdhry said. "Policy makers have the power to accelerate these advances by setting grand challenges to stimulate and direct scientific creativity; by providing targeted government funding to pursue these grand challenges; and, fostering science education and other programs that build the human scientific capital to assure the best minds are attracted to these areas.

"Policy also guides science through the establishment of ethical guidelines and regulatory requirements that specify the conditions under which new science can be brought to fruition in the marketplace, Chowdhry noted. "Such regulatory policies are currently the focus of important deb
'/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
2. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
3. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
4. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
5. DuPont Named Among Top Biotechnology Employers by Science Magazine
6. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
7. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
8. DuPont Leaders Brief Investors on Agriculture Businesses
9. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
10. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
11. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...stCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ann... ended September 30, 2009. GenVec reported a net l...e months ended September 30, 2009 compared to a ne...mparable quarter of 2008. For the nine months ende...million ($0.15 per share), compared to a net loss ...
(Date:11/5/2009)...2009 at 4:30 p.m. Eastern Time , BOTHELL, WA ...Genex Pharmaceuticals, Inc. ("OncoGenex" or the "C... financial results for the third quarter and nine ...ompany,s highlights for the third quarter of 2009....the operations of OncoGenex Technologies Inc. ("On...
(Date:11/5/2009)...re-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a...or-based technologies to discover novel flavor ing...pply industries, today provided a corporate update...ter ended September 30, 2009. Revenues were $4.2 ... $4.0 million for the third quarter of 2008, an in...
(Date:11/5/2009)...ion correction experts listed in the Trusted LASIK...recently concluded American Academy of Ophthalmolo...ifornia. Dr. Stephen Brint, MD, Dr. Frederick Frau...Rapoza, MD, Dr. Michael Raizman, MD, Dr. James McC...che, MD, and Dr. Parag Majmudar, MD, all leading v...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...derscores Intellect,s Leadership in Immunotherapy ... NEW YORK, Sept. 19 Intellect Neurosciences,Inc. ...mpany focused on,development of disease-modifying ...n of Alzheimer,s disease and related disorders, an...ering chimeric peptide vaccines has,been validated...
...o Develop New Prescription Adult Cough Products Us...Technologies, CHESTER, N.J. and SALT LAKE CITY, S...daq: ARxT ) and Lipocine Inc., a,privately- held,...y,validated proprietary technologies to address ke...y announced that they have entered into a license,...
...s Into License, Commercialization and Supply Agree.... Eastern Time, September 19, ...devus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today...ugh its acquisition of Esprit Pharma, has obtained...URA(R) XR. In connection with,Allergan,s acquisiti...
Other Biology Technology:Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 2Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 3Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 2Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 3Indevus Announces Allergan as New Partner for SANCTURA Brand 2Indevus Announces Allergan as New Partner for SANCTURA Brand 3Indevus Announces Allergan as New Partner for SANCTURA Brand 4Indevus Announces Allergan as New Partner for SANCTURA Brand 5Indevus Announces Allergan as New Partner for SANCTURA Brand 6
(Date:11/8/2009)...EALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLECT...ES , An Indiana University study involving adul...dults increased their personal health knowledge af... Adults with ID, an internationally accepted term...s of obesity, physical inactivity and preventable ...
(Date:11/6/2009)...DELPHIA (November 06, 2009) The Monell Center and...s of the Beijing International Meeting on Taste an...tion with the CAS, the meeting will be the first i... in China. , Alan Leshner, Chief Executive Offic...ience and Executive Publisher of Science magazine,...
(Date:11/4/2009)...ADS: (top news in natural science) , United St... uses less water today than it did 35 years ago, d...in water use are partly attributable to alternativ...nt irrigation systems. According to the latest USG...in the United States goes to cooling thermoelectri...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 1Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 2Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 3Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 4LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 1LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 2T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 1T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 2
...fish that belongs to the oldest living family of j...an. , This discovery, published in the March 200...ts, understanding of how color vision evolved in e...f evolution. , "It was unexpected that a ,primit...tential for color vision like humans. The discover...
... Bernard Madoff Ponzi scheme led to the collapse o...ife science research, many bioindustry observers v...uence in the larger economic picture, reports Gen... look at the Madoff factor as representing only on... has been rocked by declining stock prices, additi...
...ation for Dental Research (IADR) has selected Dr. ...chusetts, USA, as the 2009 recipient of the Pharma... award will be presented at the IADR 87th General ...ril 1, 2009,Dr. Papas is the Erling Johansen Profe...partment of General Dentistry at the,Tufts Univers...
Other Biology News:Elephant shark genome sequence leads to discovery of color perception in deep-sea fish 2GEN reports on Madoff scandal's impact on the life sciences 2Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award 2
FCS File Sanitizer from Verity Software House
Rat Anti-B7 RP1 Monoclonal Antibody, Biotin Conjugated, Clone HK5.3 from Abcam
Rabbit Anti-Human ZMYM3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: